U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032
Overview
The U.S. Combined (Multiplex) Point-Of-Care-Testing Market is expected to reach a 942.56 by 2032 and is projected to grow at a CAGR of 12.25% from 2025 to 2032.
Revenue, 2024 ()
479.72
Forecast, 2032 ()
942.56
CAGR, 2024 - 2032
12.25%
Report Coverage
U.S.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market 2018-2032
U.S. Combined (Multiplex) Point-Of-Care-Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 479.72
- Projected Market Size (2032): 942.56
- CAGR (2025-2032): 12.25%
Key Findings of U.S. Combined (Multiplex) Point-Of-Care-Testing Market
- The U.S. Combined (Multiplex) Point-Of-Care-Testing Market was valued at 942.56 in 2024.
- The U.S. Combined (Multiplex) Point-Of-Care-Testing Market is likely to grow at a CAGR of 12.25% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Less Invasive in Sample Type Segment accounted for the largest share of the market with a revenue of 453.84
- The fastest growing segment SARS-CoV-2 /Influenza A/B in Virus Type Segment grew Fastest with a CAGR of 13.16% during the forecast period from 2024 to 2032.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Scope
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Segmentation & Scope
Functionality
- Semi-Automated
- Fully Automated
Product Type
- Others
- Systems
- Assays
Sample Type
- Non-Invasive
- Less Invasive
End User
- Others
- Clinics
- Laboratories
- Hospitals
Virus Type
- Others
- Human Rhinovirus (RV)
- Rhino Scynthial Virus (RSV)
- Influenza B
- Influenza A
- SARS-CoV-2
- SARS-CoV-2 /Influenza A/B
Modality
- Standalone
- Benchtop
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in |
| Market Value in 2024 | 479.72 |
| Market Value in 2032 | 942.56 |
| CAGR (2025-2032) | 12.25% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Functionality,Product Type,Sample Type,End User,Virus Type,Modality |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 479.72 in 2024
- Key Country: U.S., leading in terms of revenue with value of 479.72 in 2024.
Segments and Scope
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Functionality
- Fully Automated is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 405.48 in the year 2024.
- Fully Automated is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.37 % in forecast period 2025-2032.
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Product Type
- Assays is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 293.30 in the year 2024.
- Assays is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.42 % in forecast period 2025-2032.
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Sample Type
- Less Invasive is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 453.84 in the year 2024.
- Less Invasive is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.28 % in forecast period 2025-2032.
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By End User
- Hospitals is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 201.48 in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.71 % in forecast period 2025-2032.
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Virus Type
- SARS-CoV-2 /Influenza A/B is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 155.42 in the year 2024.
- SARS-CoV-2 /Influenza A/B is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 13.16 % in forecast period 2025-2032.
-
U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032, By Modality
- Benchtop is the largest segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a revenue of 289.01 in the year 2024.
- Benchtop is the Fastest growing segment in U.S. Combined (Multiplex) Point-Of-Care-Testing Market to 2032 with a Growth rate of 12.35 % in forecast period 2025-2032.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Company Share Analysis
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Geographical Sales Distribution, 2018-2032
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Functionality,Product Type,Sample Type,End User,Virus Type,Modality.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 479.72(Revenue in ) in 2021.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.25% during the forecast period of 2024 to 2032.
The Less Invasive segment is expected to dominate the U.S. Combined (Multiplex) Point-Of-Care-Testing Market, holding a largest market share of 453.84 in 2024
Coming Soon....
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Scope
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Segmentation & Scope
Functionality
- Semi-Automated
- Fully Automated
Product Type
- Others
- Systems
- Assays
Sample Type
- Non-Invasive
- Less Invasive
End User
- Others
- Clinics
- Laboratories
- Hospitals
Virus Type
- Others
- Human Rhinovirus (RV)
- Rhino Scynthial Virus (RSV)
- Influenza B
- Influenza A
- SARS-CoV-2
- SARS-CoV-2 /Influenza A/B
Modality
- Standalone
- Benchtop
Frequently Asked Questions
The U.S. Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Functionality,Product Type,Sample Type,End User,Virus Type,Modality.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 479.72(Revenue in ) in 2021.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.25% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Combined (Multiplex) Point-Of-Care-Testing Market for final year is USD 942.56 ().
U.S. Combined (Multiplex) Point-Of-Care-Testing Market Company Profiling
Frequently Asked Questions
The U.S. Combined (Multiplex) Point-Of-Care-Testing Market is segmented based on Segmentation Functionality,Product Type,Sample Type,End User,Virus Type,Modality.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market was valued at USD 479.72(Revenue in ) in 2021.
U.S. Combined (Multiplex) Point-Of-Care-Testing Market is projected to grow at a CAGR of 12.25% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Combined (Multiplex) Point-Of-Care-Testing Market for final year is USD 942.56 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.